絞り込み

17410

広告

「vonoprazan」の検索結果

250件中 181件~200件表示    検索結果をPubMedで見る PubMedで見る

Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers.

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials.

Helicobacter pylori-related diseases.

Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori.

Effects of vonoprazan on intractable NSAID-induced ulcers that cannot be controlled with conventional proton pump inhibitors: a case report.

Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.

Vonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidence.

A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori.

Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.

Pharmacokinetic Drug-Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men.

Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.

Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.

Vonoprazan is superior to proton pump inhibitors (PPIs) in healing artificial ulcers post-endoscopic submucosal dissection (ESD) of the stomach: a propensity score-matching analysis.

Lansoprazole exacerbates pemetrexed-mediated hematological toxicity by competitive inhibition of renal basolateral human organic anion transporter 3.

Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.

Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.

Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations.

In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker.

  1. 6
  2. 7
  3. 8
  4. 9
  5. 10
  6. 11
  7. 12
Sort by
※並べ替えは表示に時間がかかります